Zobrazeno 1 - 10
of 438
pro vyhledávání: '"C, O'Morain"'
Autor:
S. R. Abdulkhakov, D. S. Bordin, R. A. Abdulkhakov, D. D. Safina, A. R. Gizdatullina, L. Z. Gimadieva, G. M. Safina, A. I. Ziyatdinov, A. M. Maturina, O. P. Nyssen, F. Megraud, C. O’Morain, J. Perez-Gisbert
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 52-59 (2020)
Background. As part of an observational multicenter prospective study European Registry on the management of Helicobacter pylori infection, conducted on the initiative of the European H. pylori and Microbiota Study Group, the compliance of clinical p
Externí odkaz:
https://doaj.org/article/906ccf5a34eb4cda8aa860bb54567f5d
Autor:
T. Rokkas, Y. Niv, J. Gisbert, F. Franceschi, A. Gasbarrini, G. Hold, C. O'Morain, P. Malfertheiner, F. Megraud
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
Objective: Recent randomized control trials (RCTs), have demonstrated the beneficial therapeutic effects of rifaximin for the treatment of the irritable bowel syndrome (IBS). However, in these studies different drug doses have been used and still the
Externí odkaz:
https://doaj.org/article/505d19bed0b740aa92003762021261d5
Publikováno v:
Microbiota in Health and Disease, Vol 2 (2020)
The emergence of the microbiome as a significant factor influencing health and disease across a number of organ systems has posed a new challenge for those wishing to identify the optimum treatments for Helicobacter pylori infection. This review aims
Externí odkaz:
https://doaj.org/article/8b21a2ce2faf4e7997a687a27f4a1f82
Autor:
D S Bordin, Yu V Embutnieks, L G Vologzhanina, T A Il'chishina, I N Voinovan, A S Sarsenbaeva, S A Alekseenko, O V Zaitsev, R A Abdulkhakov, M F Osipenko, M A Livzan, V V Tsukanov, S G Burkov, N V Bakulina, N N Dekhnich, L V Tarasova, E Yu Plotnikova, I V Maev, Yu A Kucheryavyi, N V Baryshnikova, M A Butov, S V Kolbasnikov, A L Pakhomova, T V Zhestkova, A Yu Baranovskii, S R Abdulkhakov, E A Ageeva, E A Lyalyukova, A V Vasyutin, N N Golubev, I V Savilova, L V Morkovkina, A G Kononova, F Megraud, C O’Morain, M Ramas, O P Nyssen, A G McNicholl, J P Gisbert
Publikováno v:
Терапевтический архив, Vol 90, Iss 2, Pp 35-42 (2018)
On behalf of the scientific Committee and researchers Hp-EuReg European Registry on the management of Helicobacter pylori infection («Hp-EuReg») - a multicenter prospective observational study initiated by the European Helicobacter and Microbiota S
Externí odkaz:
https://doaj.org/article/f4badf52df9b450396b08f98ad0c5272
Autor:
G. D. Fadieienko, O. V. Shvets, L. Moreira, O. P. Nyssen, F. Mégraud, C. O’Morain, J. P. Gisbert, O. E. Gridnyev
Publikováno v:
Modern Gastroenterology. :5-13
Current trends in the treatment of H. pylori infection in Ukraine: results of the European Registry on Helicobacter pylori Management (Hp EuReg) The European Registry on Helicobacter pylori Management (Hp EuReg) was established to evaluate the effica
Autor:
Ashwin N Ananthakrishnan, Gilaad G Kaplan, Charles N Bernstein, Kristin E Burke, Paul J Lochhead, Alexa N Sasson, Manasi Agrawal, Jimmy Ho Tuan Tiong, Joshua Steinberg, Wolfgang Kruis, Flavio Steinwurz, Vineet Ahuja, Siew C Ng, David T Rubin, Jean-Frederic Colombel, Richard Gearry, M Abreu, V Ahuja, M Allez, A Ananthakrishnan, W Bemelman, C Bernstein, J Braun, Y Chowers, J-F Colombel, S Danese, G D'Haens, A D'Hoore, A Dignass, I Dotan, M Dubinsky, A Ekbom, P Fleshner, C Gasche, MA Gassull, R Gearry, S Ghosh, P Gibson, A Griffiths, J Halfvarson, S Hanauer, N Harpaz, A Hart, T Hibi, M Kamm, G Kaplan, A Kaser, B Korelitz, P Kotze, I Koutroubakis, W Kruis, P Lakatos, J Lewis, J Lindsay, E Loftus, E Louis, M Lukas, F Magro, U Mahadevan, G Mantzaris, J-Y Mary, D McGovern, B Moum, P Munkholm, M Neurath, S Ng, C O'Morain, T Oresland, R Panaccione, J Panes, Y Panis, J Pemberton, L Peyrin-Biroulet, C Prantera, D Rachmilewitz, Z Ran, W Reinisch, F Remzi, J Rhodes, R Riddell, G Rogler, D Rubin, D Sachar, W Sandborn, B Sands, B Sartor, J Schoelmerich, S Schreiber, C Siegel, B Siegmund, M Silverberg, J Söderholm, A Sood, A Spinelli, E Stange, F Steinwurz, S Targan, S Travis, D Turner, C Tysk, M Vatn, S Vermeire, M Watanabe, T Yamamoto, J Yamamoto-Furusho
Publikováno v:
Ananthakrishnan, A N, Kaplan, G G, Bernstein, C N, Burke, K E, Lochhead, P J, Sasson, A N, Agrawal, M, Tiong, J H T, Steinberg, J, Kruis, W, Steinwurz, F, Ahuja, V, Ng, S C, Rubin, D T, Colombel, J-F, Gearry, R & International Organization for Study of Inflammatory Bowel Diseases 2022, ' Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases : an International Organization for Study of Inflammatory Bowel Diseases consensus ', The Lancet Gastroenterology & Hepatology, vol. 7, no. 7, pp. 666-678 . https://doi.org/10.1016/S2468-1253(22)00021-8
Environmental and lifestyle factors play an important role in the natural history of Crohn's disease and ulcerative colitis. A group of international experts from the International Organization for the Study of Inflammatory Bowel Diseases voted on a
Autor:
S. Prast-Nielsen, A. McNicholl, C. O’Morain, F. Megraud, J. Machado, T. Alarcon, M. Leja, A. Gasbarrini, L. Andersen, L. Engstrand, J. Gisbert, on behalf European Helicobacter and Microbiota Study Group (EHMSG; www.helicobacter.org)
Publikováno v:
Microbiota in Health and Disease, Vol 1 (2019)
Background: Helicobacter pylori eradication requires a combination of antibiotics. The short and long-term effect of different H. pylori eradication regimens on the gut microbiota has received little attention. Aims: To evaluate and compare the impa
Externí odkaz:
https://doaj.org/article/207f43f8408748ec8716b94e5b7caad4
Introduction: Management of Helicobacter pylori infection (H. pylori) re-quires co- treatment with proton pump inhibitors (PPIs) and the use of an- tibiotics to achieve successful eradicationAims & Methods: To evaluate the role of PPIs in the eradica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::f8ae16678f84f174ed26023129768260
https://www.bib.irb.hr/1246007
https://www.bib.irb.hr/1246007
Introduction: The impact of consensus, prescription choices and efficacy trends on clinical practice over time has not been studied in depth.Aims & Methods: International multicenter prospective non-intervention-al registry aimed to evaluate the deci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::b4ea272a4c2c05a287e8077f8a741531
https://www.bib.irb.hr/1245964
https://www.bib.irb.hr/1245964
Introduction: Antibiotic resistance is the main factor influencing the ef-ficacy of treatments to eradicate the infection by Helicobacter pylori (H. pylori). The treatments including clarithromycin are the most frequently used in first-line ; however
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::2e28eb5311beaa4713d5e4615a5e3a53
https://www.bib.irb.hr/1245995
https://www.bib.irb.hr/1245995